NXGL NEXGEL INC

NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022

NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022

LANGHORNE, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced that Adam Levy, CEO, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12th – 14th at the Lotte New York Palace Hotel in New York, NY.

H.C. Wainwright 24th Annual Global Investment Conference

Date: Wednesday, September 14, 2022

Time: 9:00 A.M. – 9:30 A.M. Eastern Time

Registration:

If you would like to book 1x1 investor meetings with NEXGEL, please contact your H.C. Wainwright representative or send an email to .

About NEXGEL, INC.

NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

Investor Contacts:

Valter Pinto, Managing Director

KCSA Strategic Communications

212.896.1254

Media Contacts:

Raquel Cona

KCSA Strategic Communications

212.896.1204



EN
07/09/2022

Underlying

NXGLNEXGEL INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NEXGEL INC

 PRESS RELEASE
Free
NXGL NEXGEL INC

NEXGEL Reports First Quarter 2025 Financial Results

NEXGEL Reports First Quarter 2025 Financial Results First quarter 2025 revenue totaled $2.81 million, an increase of 121%, as compared to $1.27 million for the same period the prior year Gross Profit for the quarter was 42.4%, compared to 12.6% in Q1 2024 and 37.2% in Q4 2024 LANGHORNE, Pa., May 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its first quarter 2025 financial results for the period ending March 31, 2025...

May 13, 2025 1 EN
 PRESS RELEASE
Free
NXGL NEXGEL INC

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

NEXGEL to Report First Quarter 2025 Financial Results on May 13th Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2025, after the market close on May 13, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 p.m. ET on the sa...

May 9, 2025 1 EN
 PRESS RELEASE
Free
NXGL NEXGEL INC

NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV Apr...

NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th  LANGHORNE, Pa., April 07, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will be presenting at the Planet MicroCap Showcase: Vegas 2025, taking place at the Paris Hotel & Casino, Las Vegas, NV on April 22-24, 2025. Planet MicroCap Showcase: Vegas 2025Pres...

April 7, 2025 1 EN
 PRESS RELEASE
Free
NXGL NEXGEL INC

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Resu...

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results Fourth quarter 2024 revenue totaled $3.04 million, an increase of 181%, as compared to $1.08 million for the same period the prior year Full year 2024 revenue totaled $8.69 million, an increase of 112%, as compared to $4.09 million in 2023 Over 100% full year and fourth quarter revenue growth year-over-year for third consecutive year Company issues revenue guidance of $13 million for 2025 and expects to achieve positive EBITDA during the year LANGHORNE, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXG...

March 24, 2025 1 EN
 PRESS RELEASE
Free
NXGL NEXGEL INC

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results o...

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th Management will host a conference call at 4:30 p.m. ET on the same day LANGHORNE, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the fourth quarter and full year ended December 31, 2024, after the market closes on March 24, 2025. Following the release of its financial results, the Compa...

March 19, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch